These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5799604)

  • 1. [Protection of bacteriophage from the destructive effect of gastric juice by means of pectin].
    Meshalova AN; Kilesso VA; Kalianev AV; Rukhadze EZ; Turchinskaia MV
    Zh Mikrobiol Epidemiol Immunobiol; 1969 May; 46(5):67-72. PubMed ID: 5799604
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kaopectate in the combined treatment of patients with intestinal infections].
    Gebesh VV; Ianchenko VI; Sukhov IuA
    Lik Sprava; 1999; (3):140-2. PubMed ID: 10474963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloramphenicol and terramycin in the treatment of Salmonella and Shigella infections.
    KUNSTADTER RH; MILZER A; KAGAN BM
    J Pediatr; 1951 Dec; 39(6):687-96. PubMed ID: 14898399
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of salmonellosis and shigellosis.
    Guckian JC; Perry JE
    Mod Treat; 1966 Sep; 3(5):1002-15. PubMed ID: 5915223
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of treatment of shigellosis and salmonellosis with chloromycetin, glucomycin, and sulfasuxidine.
    GOERKE LS; MOUTON CM; BOWER AG
    Ann West Med Surg; 1952 Oct; 6(10):661-4. PubMed ID: 13008372
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of bacterial cultures of Lactobacillus acidophilus (acidophilic milk) on the carrier state of Shigella and Salmonella organisms in children].
    Zychowicz C; Surazyńska A; Siewierska B; Cieplińska T
    Pediatr Pol; 1974 Aug; 49(8):997-1003. PubMed ID: 4211408
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effectiveness of biopreparations from Propionibacterium shermanii in preventing dysbacteriosis during treatment of Salmonella and Shigella infections].
    Sidorchuk II; Bondarenko VM; Patratiĭ VK; Cherevko SA; Nabukhotnyĭ TK
    Mikrobiol Zh (1978); 1984; 46(2):43-7. PubMed ID: 6400796
    [No Abstract]   [Full Text] [Related]  

  • 8. Tetracycline in the treatment of sonne dysentery and Salmonella enteritis.
    DONALD G; McKENDRICK W; MEDLOCK JM
    Public Health; 1958 Apr; 72(1):25-7. PubMed ID: 13542718
    [No Abstract]   [Full Text] [Related]  

  • 9. [Characteristics and evaluation of the clinical effectiveness of dry bacteriophage with pectin in children with dysentery].
    Orlova ZN; Garnova NA
    Vopr Okhr Materin Det; 1971 May; 16(5):84-5. PubMed ID: 5142487
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of dysentery bacteriophage as a means of preventing dysentery (review of the literature)].
    Pavlova LI; Sumarokov AA; Solodovnikov IuP; Nikitiuk NM
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Aug; 50(8):27-32. PubMed ID: 4593919
    [No Abstract]   [Full Text] [Related]  

  • 11. Some experiences with kanamycin in the treatment of Salmonella and Shigella infections.
    THURMAN WG; PLATOU RV
    Ann N Y Acad Sci; 1958 Sep; 76(2):230-4. PubMed ID: 13595513
    [No Abstract]   [Full Text] [Related]  

  • 12. Shigella and Salmonella diarrhoeal disease.
    Levine MM
    Trop Doct; 1979 Jan; 9(1):4-9. PubMed ID: 419565
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of dysentery infections in human collectivities by means of polyvalent bacteriophages S. flexneri and S. sonnei].
    Kostrzewski J; Mulczyk M; Slopek S
    Przegl Epidemiol; 1974; 28(4):483-507. PubMed ID: 4614332
    [No Abstract]   [Full Text] [Related]  

  • 14. Paromomycin in the treatment of Shigella and Salmonella infections in children.
    COLES HM; MACNAMARA B; MUTCH L; HOLT RJ; STEWART GT
    Lancet; 1960 Apr; 1(7131):944-6. PubMed ID: 13811169
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biological treatment of enteric & parenteral salmonelosis & shigellosis].
    SAPHRA I; CURBELO A; MARQUEZ V
    Arch Hosp Univ; 1957; 9(1):12-7. PubMed ID: 13436249
    [No Abstract]   [Full Text] [Related]  

  • 16. A study of Shigella by means of bacteriophage.
    THOMEN LF; FROBISHER M
    Am J Hyg; 1945 Nov; 42():225-53. PubMed ID: 21005127
    [No Abstract]   [Full Text] [Related]  

  • 17. [The microbiological aspects of using enterosorbents in acute intestinal infections].
    Nikolaeva LG
    Lik Sprava; 1993 Jul; (8):81-3. PubMed ID: 8079486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of bacteriophage in the prevention and treatment of bacillary dysentery].
    Zilişteanu C; Ionescu H; Ionescu-Dorohoi T; Coman O; Bădescu M; Brînzac V
    Arch Roum Pathol Exp Microbiol; 1973 Jun; 32(2):193-8. PubMed ID: 4584316
    [No Abstract]   [Full Text] [Related]  

  • 19. Bacteriologic studies in an epidemic of bacillary dysentery in Korea; serotypes of Shigella and Salmonella recovered and bacteriologic response to sulfadiazine, chloramphenicol, terramycin, aureomycin and streptomycin.
    ZIMMERMAN LE; COOPER M; GRABER CD
    Am J Clin Pathol; 1952 Jun; 22(6):549-57. PubMed ID: 14933330
    [No Abstract]   [Full Text] [Related]  

  • 20. [Successful use of a bacteriophage in a dysentery epidemic in a children home].
    Procházka D
    Zentralbl Bakteriol Orig; 1967 Feb; 202(3):369-73. PubMed ID: 4878032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.